Beschreibung
Fluconazole substantially increases quetiapine plasma concentrations via CYP3A4 inhibition, raising the risk of quetiapine-mediated QT prolongation and torsades de pointes.
Mechanismus
Fluconazole is a potent CYP3A4 inhibitor that reduces quetiapine clearance; both drugs also independently block hERG channels, adding pharmacodynamic risk.
Klinische Bedeutung
Quetiapine AUC may increase several-fold; QTc prolongation and torsades de pointes cases have been reported with this combination.
Maßnahmen
Avoid concurrent use; if antifungal therapy is required, use an azole with lower CYP3A4 inhibitory potential or reduce quetiapine dose with ECG monitoring.
Medizinischer Haftungsausschluss
This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.